{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T09:10:11Z","timestamp":1787735411567,"version":"build-2784847793"},"reference-count":125,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.lfs.2017.09.033","type":"journal-article","created":{"date-parts":[[2017,9,28]],"date-time":"2017-09-28T23:01:22Z","timestamp":1506639682000},"page":"68-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Research progress of mechanisms and drug therapy for neuropathic pain"],"prefix":"10.1016","volume":"190","author":[{"given":"Yun-yi","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-yao","family":"Ao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-rong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-man","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2017.09.033_bb0005","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cell.2009.09.028","article-title":"Cellular and molecular mechanisms of pain","volume":"139","author":"Basbaum","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2017.09.033_bb0010","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1212\/01.wnl.0000282763.29778.59","article-title":"Neuropathic pain: redefinition and a grading system for clinical and research purposes","volume":"70","author":"Treede","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.lfs.2017.09.033_bb0015","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.mcna.2015.08.009","article-title":"Managing neuropathic pain","volume":"100","author":"Jones","year":"2016","journal-title":"Med. Clin. North Am."},{"key":"10.1016\/j.lfs.2017.09.033_bb0020","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.neuron.2016.01.034","article-title":"A systems-level analysis of the peripheral nerve intrinsic axonal growth program","volume":"89","author":"Chandran","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.lfs.2017.09.033_bb0025","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1212\/WNL.0000000000002478","article-title":"Dorsal horn circuitry: complexity and implications for mechanisms of neuropathic pain","volume":"86","author":"Benarroch","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.lfs.2017.09.033_bb0030","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/ejn.12466","article-title":"Pro-neurotrophins, sortilin, and nociception","volume":"39","author":"Lewin","year":"2014","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.lfs.2017.09.033_bb0035","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.autrev.2016.02.011","article-title":"Autoantibody pain","volume":"15","author":"Goebel","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.lfs.2017.09.033_bb0040","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.neubiorev.2014.08.002","article-title":"Emotional consequences of neuropathic pain: insight from preclinical studies","volume":"47","author":"Yalcin","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.lfs.2017.09.033_bb0045","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jaad.2015.04.060","article-title":"Neurocutaneous disease: cutaneous neuroanatomy and mechanisms of itch and pain","volume":"74","author":"Chuquilin","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.lfs.2017.09.033_bb0050","series-title":"Massachusetts General Hospital., Ovid Technologies Inc. The Massachusetts General Hospital handbook of pain management","author":"Ballantyne","year":"2006"},{"key":"10.1016\/j.lfs.2017.09.033_bb0055","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s12035-014-8706-9","article-title":"Peripheral nerve injury modulates neurotrophin signaling in the peripheral and central nervous system","volume":"50","author":"Richner","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.lfs.2017.09.033_bb0060","doi-asserted-by":"crossref","DOI":"10.6064\/2012\/561761","article-title":"The perception and endogenous modulation of pain","volume":"2012","author":"Ossipov","year":"2012","journal-title":"Scientifica"},{"key":"10.1016\/j.lfs.2017.09.033_bb0065","doi-asserted-by":"crossref","first-page":"10657","DOI":"10.3390\/molecules200610657","article-title":"Neurotrophins and neuropathic pain: role in pathobiology","volume":"20","author":"Khan","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.lfs.2017.09.033_bb0070","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.nbd.2015.04.012","article-title":"Exogenous induction of HO-1 alleviates vincristine-induced neuropathic pain by reducing spinal glial activation in mice","volume":"79","author":"Shen","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.lfs.2017.09.033_bb0075","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s12565-012-0163-9","article-title":"Expression of ATP receptors in the rat dorsal root ganglion and spinal cord","volume":"88","author":"Kobayashi","year":"2013","journal-title":"Anat. Sci. Int."},{"key":"10.1016\/j.lfs.2017.09.033_bb0080","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.neuropharm.2015.10.003","article-title":"Opioids and TRPV1 in the peripheral control of neuropathic pain\u2014defining a target site in the injured nerve","volume":"101","author":"Labuz","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.lfs.2017.09.033_bb0085","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2174\/1381612820666141027124506","article-title":"Acid-sensingion channels: a novel therapeutic target for pain and anxiety","volume":"21","author":"Li","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.lfs.2017.09.033_bb0090","first-page":"373","article-title":"Anti-nerve growth factor in pain management: current evidence","volume":"9","author":"Chang","year":"2016","journal-title":"J. Pain Res."},{"key":"10.1016\/j.lfs.2017.09.033_bb0095","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1007\/s11064-008-9717-6","article-title":"Characteristics of HCN channels and their participation in neuropathic pain","volume":"33","author":"Jiang","year":"2008","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.lfs.2017.09.033_bb0100","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/01.j.pain.0000460334.49525.5e","article-title":"Peripheral and spinal mechanisms of nociception in a rat reserpine-induced pain model","volume":"156","author":"Taguchi","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.lfs.2017.09.033_bb0105","doi-asserted-by":"crossref","first-page":"8959","DOI":"10.1523\/JNEUROSCI.3558-14.2015","article-title":"The role of G-protein receptor 84 in experimental neuropathic pain","volume":"35","author":"Nicol","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.lfs.2017.09.033_bb0110","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/bs.apha.2015.12.006","article-title":"Sodium channels in pain and cancer: new therapeutic opportunities","volume":"75","author":"Luiz","year":"2016","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.lfs.2017.09.033_bb0115","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.celrep.2013.12.033","article-title":"Pain without nociceptors? Nav1.7-independent pain mechanisms","volume":"6","author":"Minett","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.lfs.2017.09.033_bb0120","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.neuroscience.2009.08.037","article-title":"Abnormal expression of voltage-gated sodium channels Nav1.7, Nav1.3 and Nav1.8 in trigeminal neuralgia","volume":"164","author":"Siqueira","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.lfs.2017.09.033_bb0125","article-title":"SDF1-CXCR4 signaling contributes to the transition from acute to chronic pain state","author":"Yang","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.lfs.2017.09.033_bb0130","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.bbadis.2013.01.017","article-title":"Specific functioning of Cav3.2 T-type calcium and TRPV1 channels under different types of STZ-diabetic neuropathy","volume":"1832","author":"Khomula","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.lfs.2017.09.033_bb0135","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.expneurol.2016.11.003","article-title":"Cisplatin-induced neuropathic pain is mediated by upregulation of N-type voltage-gated calcium channels in dorsal root ganglion neurons","volume":"288","author":"Leo","year":"2017","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.lfs.2017.09.033_bb0140","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.2337\/db13-0813","article-title":"Reversal of neuropathic pain in diabetes by targeting glycosylation of Ca(V)3.2 T-type calcium channels","volume":"62","author":"Orestes","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.lfs.2017.09.033_bb0145","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejphar.2016.11.001","article-title":"N- and L-type calcium channels blocker cilnidipine ameliorates neuropathic pain","volume":"793","author":"Yamamoto","year":"2016","journal-title":"Eur. J. Pharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.lfs.2017.09.033_bb0150","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1097\/j.pain.0000000000000368","article-title":"Potassium channels in neuropathic pain: advances, challenges, and emerging ideas","volume":"157","author":"Busserolles","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.lfs.2017.09.033_bb0155","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1523\/JNEUROSCI.3145-09.2010","article-title":"Knockdown of L calcium channel subtypes: differential effects in neuropathic pain","volume":"30","author":"Fossat","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.lfs.2017.09.033_bb0160","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1172\/JCI65364","article-title":"signaling underlies the pathogenesis of neuropathic pain in rodents","volume":"123","author":"Zhang","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2017.09.033_bb0165","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000455987","article-title":"MicroRNA-183 Suppresses Neuropathic Pain and Expression of AMPA Receptors by Targeting mTOR\/VEGF Signaling Pathway","volume":"41","author":"Xie","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.lfs.2017.09.033_bb0170","first-page":"901","article-title":"Neuronal plasticity and neuropathic pain","volume":"66","author":"Amantea","year":"2000","journal-title":"Minerva Anestesiol."},{"key":"10.1016\/j.lfs.2017.09.033_bb0175","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0304-3959(99)00227-4","article-title":"Long-term changes in sciatic-evoked A-fiber dorsal horn field potentials accompany loose ligation of the sciatic nerve in rats","volume":"84","author":"Miletic","year":"2000","journal-title":"Pain"},{"issue":"1049","key":"10.1016\/j.lfs.2017.09.033_bb0180","article-title":"Successful pain relief in non-responders to spinal cord stimulation: the combined use of ketamine and spinal cord stimulation","volume":"15","author":"Truin","year":"2011","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.lfs.2017.09.033_bb0185","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10604","article-title":"Intracellular mGluR5 plays a critical role in neuropathic pain","volume":"7","author":"Vincent","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2017.09.033_bb0190","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1038\/ncomms6331","article-title":"Presynaptic GABAergic inhibition regulated by BDNF contributes to neuropathic pain induction","volume":"5","author":"Chen","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2017.09.033_bb0195","doi-asserted-by":"crossref","first-page":"6057","DOI":"10.1523\/JNEUROSCI.4495-14.2015","article-title":"Engagement of the GABA to KCC2 signaling pathway contributes to the analgesic effects of A3AR agonists in neuropathic pain","volume":"35","author":"Ford","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.lfs.2017.09.033_bb0200","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.neuropharm.2010.11.026","article-title":"HZ166, a novel GABAA receptor subtype-selective benzodiazepine site ligand, is antihyperalgesic in mouse models of inflammatory and neuropathic pain","volume":"60","author":"Di Lio","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.lfs.2017.09.033_bb0205","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.phrs.2016.12.019","article-title":"New approaches to target glycinergic neurotransmission for the treatment of chronic pain","volume":"116","author":"Imlach","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.lfs.2017.09.033_bb0210","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s12031-009-9224-5","article-title":"Effect of memantine on the levels of neuropeptides and microglial cells in the brain regions of rats with neuropathic pain","volume":"39","author":"Takeda","year":"2009","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.lfs.2017.09.033_bb0215","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/jdi.12379","article-title":"Microglia in the spinal cord and neuropathic pain","volume":"7","author":"Tsuda","year":"2016","journal-title":"J. Diabetes Investig."},{"key":"10.1016\/j.lfs.2017.09.033_bb0220","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.neubiorev.2008.03.009","article-title":"Spinal glial activation contributes to pathological pain states","volume":"32","author":"Cao","year":"2008","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.lfs.2017.09.033_bb0225","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.phrs.2016.11.019","article-title":"Therapeutic implications of toll-like receptors in peripheral neuropathic pain","volume":"115","author":"Thakur","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.lfs.2017.09.033_bb0230","first-page":"483","article-title":"Contribution of primary sensory neurons and spinal glial cells to pathomechanisms of neuropathic pain","volume":"60","author":"Obata","year":"2008","journal-title":"Brain Nerve"},{"key":"10.1016\/j.lfs.2017.09.033_bb0235","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nn.4217","article-title":"A peripheral messenger for chronic pain","volume":"19","author":"Thuault","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.lfs.2017.09.033_bb0240","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.coph.2011.10.015","article-title":"Chemokine mediated neuron-glia communication and aberrant signalling in neuropathic pain states","volume":"12","author":"Old","year":"2012","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.lfs.2017.09.033_bb0245","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.coph.2011.10.007","article-title":"Chemokines and cytokines in neuroinflammation leading to neuropathic pain","volume":"12","author":"Kiguchi","year":"2012","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.lfs.2017.09.033_bb0250","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1515\/bmc-2014-0022","article-title":"Epigenetic regulation of CC-chemokine ligand 2 in nonresolving inflammation","volume":"5","author":"Kiguchi","year":"2014","journal-title":"Biomol. Concepts"},{"key":"10.1016\/j.lfs.2017.09.033_bb0255","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.bcp.2013.11.019","article-title":"Biochemical and pharmacological assessment of MAP-kinase signaling along pain pathways in experimental rodent models: a potential tool for the discovery of novel antinociceptive therapeutics","volume":"87","author":"Edelmayer","year":"2014","journal-title":"Biochem. Pharmacol."},{"issue":"Pt 1","key":"10.1016\/j.lfs.2017.09.033_bb0260","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.expneurol.2015.11.001","article-title":"Celecoxib reverts oxaliplatin-induced neuropathic pain through inhibiting PI3K\/Akt2 pathway in the mouse dorsal root ganglion","volume":"275","author":"Jiang","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.lfs.2017.09.033_bb0265","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.expneurol.2007.05.029","article-title":"Activation of phosphatidylinositol 3-kinase and protein kinase B\/Akt in dorsal root ganglia and spinal cord contributes to the neuropathic pain induced by spinal nerve ligation in rats","volume":"206","author":"Xu","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.lfs.2017.09.033_bb0270","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1523\/JNEUROSCI.2139-10.2011","article-title":"Spinal phosphinositide 3-kinase-Akt-mammalian target of rapamycin signaling cascades in inflammation-induced hyperalgesia","volume":"31","author":"Xu","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.lfs.2017.09.033_bb0275","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s12974-015-0458-6","article-title":"Ligand engagement of Toll-like receptors regulates their expression in cortical microglia and astrocytes","volume":"12","author":"Marinelli","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.lfs.2017.09.033_bb0280","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5238730","article-title":"Blockade of toll-like receptors (TLR2, TLR4) attenuates pain and potentiates buprenorphine analgesia in a rat neuropathic pain model","volume":"2016","author":"Jurga","year":"2016","journal-title":"Neural Plast."},{"key":"10.1016\/j.lfs.2017.09.033_bb0285","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1523\/JNEUROSCI.1161-14.2015","article-title":"Caveolin-1 in the anterior cingulate cortex modulates chronic neuropathic pain via regulation of NMDA receptor 2B subunit","volume":"35","author":"Yang","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.lfs.2017.09.033_bb0290","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMp1704633","article-title":"Gabapentin and pregabalin for pain - is increased prescribing a cause for concern?","volume":"377","author":"Goodman","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2017.09.033_bb0295","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S1470-2045(05)70317-X","article-title":"Controversies in pharmacotherapy of pain management","volume":"6","author":"Davis","year":"2005","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lfs.2017.09.033_bb0300","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005454.pub2","article-title":"Antidepressants for neuropathic pain","author":"Saarto","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.lfs.2017.09.033_bb0305","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2165\/00023210-200822050-00005","article-title":"An update on the pharmacological management of post-herpetic neuralgia and painful diabetic neuropathy","volume":"22","author":"Zin","year":"2008","journal-title":"CNS Drugs"},{"key":"10.1016\/j.lfs.2017.09.033_bb0310","first-page":"227","article-title":"Treating painful diabetic peripheral neuropathy: an update","volume":"94","author":"Snyder","year":"2016","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.lfs.2017.09.033_bb0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC guideline for prescribing opioids for chronic pain - United States, 2016","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recomm. Rep."},{"key":"10.1016\/j.lfs.2017.09.033_bb0320","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.neuroscience.2016.06.057","article-title":"Antidepressants and gabapentinoids in neuropathic pain: mechanistic insights","volume":"338","author":"Kremer","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.lfs.2017.09.033_bb0325","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pain.2007.08.033","article-title":"Pharmacologic management of neuropathic pain: evidence-based recommendations","volume":"132","author":"Dworkin","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.lfs.2017.09.033_bb0330","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1056\/NEJMc1705241","article-title":"Trial of pregabalin for acute and chronic sciatica","volume":"376","author":"Maher","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2017.09.033_bb0335","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s40266-015-0293-6","article-title":"Pharmaceutical management of trigeminal neuralgia in the elderly","volume":"32","author":"Oomens","year":"2015","journal-title":"Drugs Aging"},{"key":"10.1016\/j.lfs.2017.09.033_bb0340","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1001\/archneur.60.11.1524","article-title":"Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations","volume":"60","author":"Dworkin","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.lfs.2017.09.033_bb0345","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD011603","article-title":"Amitriptyline for neuropathic pain in adults","author":"Moore","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.lfs.2017.09.033_bb0350","first-page":"219","article-title":"Desvenlafaxine and neuropathic pain: additional clinical benefits of a second generation serotonin-noradrenaline reuptake inhibitor","volume":"64","author":"Alcantara-Montero","year":"2017","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.lfs.2017.09.033_bb0355","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.pain.2010.06.019","article-title":"The evidence for pharmacological treatment of neuropathic pain","volume":"150","author":"Finnerup","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.lfs.2017.09.033_bb0360","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1213\/01.ANE.0000141061.74294.DE","article-title":"The evolving and important role of anesthesiology in palliative care","volume":"100","author":"Fine","year":"2005","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.lfs.2017.09.033_bb0365","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMe030014","article-title":"Opioids and chronic neuropathic pain","volume":"348","author":"Foley","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 11","key":"10.1016\/j.lfs.2017.09.033_bb0370","first-page":"S276","article-title":"Opioid pharmacokinetic drug-drug interactions","volume":"17","author":"Overholser","year":"2011","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.lfs.2017.09.033_bb0375","article-title":"Tramadol for neuropathic pain in adults","volume":"6","author":"Duehmke","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.lfs.2017.09.033_bb0380","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1056\/NEJMsr1706626","article-title":"The role of science in addressing the opioid crisis","volume":"377","author":"Volkow","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2017.09.033_bb0385","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010902.pub2","article-title":"Oral nonsteroidal anti-inflammatory drugs for neuropathic pain","author":"Moore","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.lfs.2017.09.033_bb0390","doi-asserted-by":"crossref","DOI":"10.1177\/1744806916671523","article-title":"MicroRNA-30b regulates expression of the sodium channel Nav1.7 in nerve injury-induced neuropathic pain in the rat","volume":"12","author":"Shao","year":"2016","journal-title":"Mol. Pain"},{"key":"10.1016\/j.lfs.2017.09.033_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(17)30017-0","article-title":"Selective sodium channel blockers in trigeminal neuralgia","author":"Jensen","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.lfs.2017.09.033_bb0400","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nrd.2017.87","article-title":"Breaking barriers to novel analgesic drug development","volume":"16","author":"Yekkirala","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.lfs.2017.09.033_bb0405","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1744-8069-10-77","article-title":"NMP-7 inhibits chronic inflammatory and neuropathic pain via block of Cav3.2 T-type calcium channels and activation of CB2 receptors","volume":"10","author":"Berger","year":"2014","journal-title":"Mol. Pain"},{"key":"10.1016\/j.lfs.2017.09.033_bb0410","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12990-015-0011-8","article-title":"Small organic molecule disruptors of Cav3.2 - USP5 interactions reverse inflammatory and neuropathic pain","volume":"11","author":"Gadotti","year":"2015","journal-title":"Mol. Pain"},{"key":"10.1016\/j.lfs.2017.09.033_bb0415","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s00424-014-1566-3","article-title":"1,4-Dihydropyridine derivatives with T-type calcium channel blocking activity attenuate inflammatory and neuropathic pain","volume":"467","author":"Bladen","year":"2015","journal-title":"Arch. Eur. J. Physiol."},{"key":"10.1016\/j.lfs.2017.09.033_bb0420","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00424-015-1733-1","article-title":"Effect of the T-type channel blocker KYS-05090S in mouse models of acute and neuropathic pain","volume":"468","author":"M'Dahoma","year":"2016","journal-title":"Arch. Eur. J. Physiol."},{"key":"10.1016\/j.lfs.2017.09.033_bb0425","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1097\/j.pain.0000000000000565","article-title":"Therapeutic potential of RQ-00311651, a novel T-type Ca2+ channel blocker, in distinct rodent models for neuropathic and visceral pain","volume":"157","author":"Sekiguchi","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.lfs.2017.09.033_bb0430","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1097\/j.pain.0000000000000263","article-title":"A randomized double-blind, placebo-, and active-controlled study of T-type calcium channel blocker ABT-639 in patients with diabetic peripheral neuropathic pain","volume":"156","author":"Ziegler","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.lfs.2017.09.033_bb0435","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/1049909112441387","article-title":"Successful use of flupirtine in refractory neuropathic pain due to small fiber neuropathy","volume":"30","author":"Mishra","year":"2013","journal-title":"Am. J. Hosp. Palliat. Care"},{"key":"10.1016\/j.lfs.2017.09.033_bb0440","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1021\/jm901497b","article-title":"Novel KCNQ2\/Q3 agonists as potential therapeutics for epilepsy and neuropathic pain","volume":"53","author":"Fritch","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.lfs.2017.09.033_bb0445","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/phar.1709","article-title":"Nabilone for the management of pain","volume":"36","author":"Tsang","year":"2016","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.lfs.2017.09.033_bb0450","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.pain.2013.02.007","article-title":"Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models","volume":"154","author":"Vincenzi","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.lfs.2017.09.033_bb0455","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.nbd.2009.09.021","article-title":"1-(2\u2032,4\u2032-Dichlorophenyl)-6-methyl-N-cyclohexylamine-1,4-dihydroindeno[1,2-c]pyraz ole-3-carboxamide, a novel CB2 agonist, alleviates neuropathic pain through functional microglial changes in mice","volume":"37","author":"Luongo","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.lfs.2017.09.033_bb0460","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1124\/jpet.117.241901","article-title":"Cannabinoid CB2 agonist GW405833 suppresses inflammatory and neuropathic pain through a CB1 mechanism that is independent of CB2 receptors in mice","volume":"362","author":"Li","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.lfs.2017.09.033_bb0465","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1124\/jpet.107.119941","article-title":"The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3\u2032-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice","volume":"322","author":"Russo","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.lfs.2017.09.033_bb0470","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ejmech.2015.12.036","article-title":"Potent multitarget FAAH-COX inhibitors: design and structure-activity relationship studies","volume":"109","author":"Migliore","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.lfs.2017.09.033_bb0475","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.phrs.2016.06.012","article-title":"The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain","volume":"111","author":"Malek","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.lfs.2017.09.033_bb0480","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.pain.2012.04.020","volume":"153","author":"Huggins","year":"2012","journal-title":"Pain"},{"key":"10.1016\/j.lfs.2017.09.033_bb0485","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.lpm.2017.01.007","article-title":"Letter on the article \u201cThe BIAL\/Biotrial case of death of a human volunteer in the first-in-human study of BIA 10-2474: Are we missing the fundamentals?\u201d","volume":"46","author":"Hill","year":"2017","journal-title":"Presse Med."},{"key":"10.1016\/j.lfs.2017.09.033_bb0490","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152405","article-title":"Subtype-selective small molecule inhibitors reveal a fundamental role for Nav1.7 in nociceptor electrogenesis, axonal conduction and presynaptic release","volume":"11","author":"Alexandrou","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2017.09.033_bb0495","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrn3404","article-title":"The Na(V)1.7 sodium channel: from molecule to man","volume":"14","author":"Dib-Hajj","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.lfs.2017.09.033_bb0500","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1113\/jphysiol.2010.203463","article-title":"The Cav3.2 T-type calcium channel regulates temporal coding in mouse mechanoreceptors","volume":"589","author":"Wang","year":"2011","journal-title":"J. Physiol."},{"key":"10.1016\/j.lfs.2017.09.033_bb0505","doi-asserted-by":"crossref","DOI":"10.1177\/1744806916642444","article-title":"A cell-permeant peptide corresponding to the cUBP domain of USP5 reverses inflammatory and neuropathic pain","volume":"12","author":"Garcia-Caballero","year":"2016","journal-title":"Mol. Pain"},{"key":"10.1016\/j.lfs.2017.09.033_bb0510","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1021\/jm060989l","article-title":"Kv7 (KCNQ) channel modulators and neuropathic pain","volume":"50","author":"Munro","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.lfs.2017.09.033_bb0515","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00011-013-0592-5","article-title":"Flupirtine, a re-discovered drug, revisited","volume":"62","author":"Szelenyi","year":"2013","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.lfs.2017.09.033_bb0520","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1002\/cne.23019","article-title":"Kv7.5 is the primary Kv7 subunit expressed in C-fibers","volume":"520","author":"King","year":"2012","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.lfs.2017.09.033_bb0525","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/ejn.12440","article-title":"Endocannabinoids and neuropathic pain: focus on neuron-glia and endocannabinoid-neurotrophin interactions","volume":"39","author":"Luongo","year":"2014","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.lfs.2017.09.033_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2017.02.019","article-title":"Allodynia lowering induced by cannabinoids and endocannabinoids (ALICE)","author":"Luongo","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.lfs.2017.09.033_bb0535","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1124\/jpet.116.236539","article-title":"Two janus cannabinoids that are both CB2 agonists and CB1 antagonists","volume":"360","author":"Dhopeshwarkar","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.lfs.2017.09.033_bb0540","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/cmdc.201402374","article-title":"O-(triazolyl)methyl carbamates as a novel and potent class of fatty acid amide hydrolase (FAAH) inhibitors","volume":"10","author":"Colombano","year":"2015","journal-title":"ChemMedChem"},{"key":"10.1016\/j.lfs.2017.09.033_bb0545","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1126\/science.aaf7497","article-title":"Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474","volume":"356","author":"van Esbroeck","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.lfs.2017.09.033_bb0550","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1007\/s00213-015-4140-6","article-title":"Effects of fatty acid amide hydrolase (FAAH) inhibitors on working memory in rats","volume":"233","author":"Panlilio","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.lfs.2017.09.033_bb0555","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1021\/jf102559q","article-title":"Epoxygenated fatty acids and soluble epoxide hydrolase inhibition: novel mediators of pain reduction","volume":"59","author":"Wagner","year":"2011","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.lfs.2017.09.033_bb0560","doi-asserted-by":"crossref","first-page":"9082","DOI":"10.1073\/pnas.1510137112","article-title":"Endoplasmic reticulum stress in the peripheral nervous system is a significant driver of neuropathic pain","volume":"112","author":"Inceoglu","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2017.09.033_bb0565","doi-asserted-by":"crossref","first-page":"7016","DOI":"10.1021\/jm500694p","article-title":"Optimized inhibitors of soluble epoxide hydrolase improve in vitro target residence time and in vivo efficacy","volume":"57","author":"Lee","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.lfs.2017.09.033_bb0570","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1610325114","article-title":"Anti-inflammatory omega-3 endocannabinoid epoxides","volume":"114","author":"McDougle","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2017.09.033_bb0575","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.phrs.2015.04.001","article-title":"Peripheral FAAH and soluble epoxide hydrolase inhibitors are synergistically antinociceptive","volume":"97","author":"Sasso","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.lfs.2017.09.033_bb0580","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jneuroim.2016.07.015","article-title":"Neuron-astrocyte interactions in spinal cord dorsal horn in neuropathic pain development and docosahexaenoic acid therapy","volume":"298","author":"Manzhulo","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.lfs.2017.09.033_bb0585","first-page":"521","article-title":"Polyunsaturated fatty acids and chronic pain: a systematic review and meta-analysis","volume":"19","author":"Prego-Dominguez","year":"2016","journal-title":"Pain Physician"},{"key":"10.1016\/j.lfs.2017.09.033_bb0590","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/01.j.pain.0000460348.84965.47","article-title":"Targeted alterations in dietary n-3 and n-6 fatty acids improve life functioning and reduce psychological distress among patients with chronic headache: a secondary analysis of a randomized trial","volume":"156","author":"Ramsden","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.lfs.2017.09.033_bb0595","article-title":"Fish oil a potential treatment for diabetic peripheral neuropathy?","author":"Yorek","year":"2017","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.lfs.2017.09.033_bb0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2017.03.005","article-title":"Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors","author":"Chiang","year":"2017","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.lfs.2017.09.033_bb0605","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1146\/annurev.immunol.25.022106.141647","article-title":"Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways","volume":"25","author":"Serhan","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.lfs.2017.09.033_bb0610","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0254-6272(09)60031-5","article-title":"The warming acupuncture for treatment of sciatica in 30 cases","volume":"29","author":"Chen","year":"2009","journal-title":"J. Tradit. Chin. Med."},{"key":"10.1016\/j.lfs.2017.09.033_bb0615","first-page":"763","article-title":"Clinical research of primary trigeminal neuralgia treated with electroacupuncture at qi streets acupoints combined with spinal regulation therapy","volume":"34","author":"Yang","year":"2014","journal-title":"Zhongguo Zhen Jiu"},{"key":"10.1016\/j.lfs.2017.09.033_bb0620","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2519\/jospt.2017.7089","article-title":"Dry needling combined with physical therapy in patients with chronic postsurgical pain following total knee arthroplasty: a case series","volume":"47","author":"Nunez-Cortes","year":"2017","journal-title":"J. Orthop. Sports Phys. Ther."},{"key":"10.1016\/j.lfs.2017.09.033_bb0625","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1056\/NEJMclde1701008","article-title":"Management of sciatica","volume":"376","author":"Ramaswami","year":"2017","journal-title":"N. Engl. J. Med."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320517304836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320517304836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T02:58:09Z","timestamp":1535338689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320517304836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":125,"alternative-id":["S0024320517304836"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2017.09.033","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Research progress of mechanisms and drug therapy for neuropathic pain","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2017.09.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}